• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流对重组组织型纤溶酶原激活剂诱导的肺血栓溶解的影响。

Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis.

作者信息

Prewitt R M, Gu S A, Greenberg D, Chan S M, Schick U, La Pointe H, Ducas J

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

J Appl Physiol (1985). 1991 Oct;71(4):1441-6. doi: 10.1152/jappl.1991.71.4.1441.

DOI:10.1152/jappl.1991.71.4.1441
PMID:1757368
Abstract

We employed a canine model of pulmonary embolism induced by injection of radioactive blood clots to investigate effects of changes in cardiac output (CO) on recombinant tissue plasminogen activator- (rtPA) induced pulmonary thrombolysis. Rate and extent of thrombolysis were assessed with a gamma camera. Eighteen dogs were studied. Emboli increased mean pulmonary arterial pressure and decreased CO from 2.6 to 1.9 l/min (P less than 0.001). Subsequently, dogs were randomly divided into three groups: group 1 received 0.5 mg/kg of rtPA over 30 min; 30 min before the same dose regimen of rtPA, in the six group 2 dogs, mean CO was increased to approximately 3.25 l/min by opening one systemic arteriovenous fistula; in the six group 3 dogs, before rtPA, mean CO was increased to approximately 4.5 l/min by opening two or three fistulas. After embolization, CO remained low in group 1; the mean 2-h time-averaged CO was 1.8 l/min. CO was much higher in groups 2 and 3 (3.3 and 4.6 l/min, respectively; both P less than 0.001 compared with group 1; and P less than 0.001, group 2 vs. group 3). Compared with group 1, corresponding to the increased flow in groups 2 and 3, rate and extent of pulmonary thrombolysis significantly increased. These results indicate that an increase in flow per se augments rtPA-induced pulmonary thrombolysis. Also, because thrombolysis was similar between groups 2 and 3, these results define an upper limit to the flow-thrombolytic relationship with rtPA.

摘要

我们采用注射放射性血凝块诱导的犬肺栓塞模型,以研究心输出量(CO)变化对重组组织型纤溶酶原激活剂(rtPA)诱导的肺血栓溶解的影响。用γ相机评估血栓溶解的速率和程度。对18只犬进行了研究。栓塞使平均肺动脉压升高,CO从2.6升/分钟降至1.9升/分钟(P<0.001)。随后,将犬随机分为三组:第1组在30分钟内接受0.5毫克/千克的rtPA;在第2组的6只犬中,在给予相同剂量方案的rtPA前30分钟,通过开放一个体动静脉瘘使平均CO增加至约3.25升/分钟;在第3组的6只犬中,在rtPA前,通过开放两个或三个瘘使平均CO增加至约4.5升/分钟。栓塞后,第1组的CO仍较低;平均2小时时间平均CO为1.8升/分钟。第2组和第3组的CO要高得多(分别为3.3升/分钟和4.6升/分钟;与第1组相比,两者P<0.001;第2组与第3组相比,P<0.001)。与第1组相比,对应于第2组和第3组血流的增加,肺血栓溶解的速率和程度显著增加。这些结果表明,血流本身的增加可增强rtPA诱导的肺血栓溶解。此外,由于第2组和第3组之间的血栓溶解相似,这些结果确定了与rtPA的血流-溶栓关系的上限。

相似文献

1
Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis.血流对重组组织型纤溶酶原激活剂诱导的肺血栓溶解的影响。
J Appl Physiol (1985). 1991 Oct;71(4):1441-6. doi: 10.1152/jappl.1991.71.4.1441.
2
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.肼屈嗪及心输出量增加对犬肺栓塞模型中重组组织型纤溶酶原激活剂诱导溶栓的影响
Chest. 1991 Mar;99(3):708-14. doi: 10.1378/chest.99.3.708.
3
Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.犬肺栓塞的溶栓治疗。尿激酶和重组组织型纤溶酶原激活剂的比较效果。
Am Rev Respir Dis. 1990 Feb;141(2):290-5. doi: 10.1164/ajrccm/141.2.290.
4
Effect of low-molecular-weight heparin on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.低分子量肝素对犬肺栓塞中重组组织型纤溶酶原激活剂诱导溶栓的影响。
Chest. 1991 Aug;100(2):464-9. doi: 10.1378/chest.100.2.464.
5
Principles of thrombolysis in pulmonary embolism.肺栓塞溶栓治疗原则
Chest. 1991 Apr;99(4 Suppl):157S-164S. doi: 10.1378/chest.99.4.157s.
6
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.冠状动脉溶栓。冠状动脉内注射重组组织型纤溶酶原激活剂与尿激酶的比较效果。
Chest. 1992 Jun;101(6):1684-90. doi: 10.1378/chest.101.6.1684.
7
Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.重组组织型纤溶酶原激活剂的静脉给药。优化冠状动脉溶栓速率。
Chest. 1995 Apr;107(4):1146-51. doi: 10.1378/chest.107.4.1146.
8
Optimizing coronary thrombolysis with i.v. administration of recombinant tissue plasminogen activator. Single bolus vs double bolus vs front-loading.静脉注射重组组织型纤溶酶原激活剂优化冠状动脉溶栓治疗。单次推注与两次推注与负荷剂量法。
Chest. 1996 Feb;109(2):510-5. doi: 10.1378/chest.109.2.510.
9
Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator.
J Am Coll Cardiol. 1992 Dec;20(7):1626-33. doi: 10.1016/0735-1097(92)90459-z.
10
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.在狭窄犬冠状动脉中使用rtPA溶栓期间,依诺肝素、希美加群和肝素作为辅助抗血栓治疗的比较。
Thromb Haemost. 1997 Oct;78(4):1278-85.